New medication offers less frequent doses to reduce bleeding episodes in patients with Hemophilia A and B. The U.S. Food and Drug Administration has recently approved Qfitlia (fitusiran)…
Read MoreMedication
State Department Cuts $60+ Billion in Wasteful Spending
Secretary Rubio has retained programs that met specific criteria and support U.S. interests. The State Department has saved $60 billion in taxpayer funding after thoroughly reviewing all grants…
Read More
HHS Secretary Launches Review of Childhood ADHD, Depression Medication
He claims that medications have been overprescribed. Secretary of Health and Human Services (HHS) Robert F. Kennedy, Jr. has made prescriptions for childhood chronic diseases, like attention-deficit/hyperactivity disorder…
Read More
FDA Approves First Treatment for Rare Disease
Ctexli offers hope for patients with a previously untreated metabolic disorder, Cerebrotendinous Xanthomatosis. The U.S. Food and Drug Administration (FDA) has approved Ctexli (chenodiol) as the first treatment…
Read More
Defense Secretary Realigns U.S. Military Focus to “One Force”
He implements the president’s executive order prohibiting transgender individuals in the military. Secretary of Defense Pete Hegseth sent a one-page memo to all military employees, directing them to…
Read More
Congressman Freezes During House Floor Speech
Representative Larson’s office states it is a side effect from a new medication. Congressman John Larson of Connecticut froze during a speech on the floor of the House…
Read More
Defense Department Applies AI Chatbots in Military Medicine Pilot
Chief Digital and Artificial Intelligence Office provides the latest report. The Department of Defense reported that its artificial intelligence (AI) office successfully concluded a pilot program that tested…
Read More
Federal Court Rules in Favor of Generic Drug Competition in Patent Case
The court orders the removal of improper patent listings, clearing the path for lower-cost medications. The Federal Circuit U.S. Court of Appeals recently upheld a lower court’s decision…
Read More
FDA Approves Medication for Rare Adrenal Gland Disorder
Crenessity reduces glucocorticoid dependency and improves hormone control for classic CAH. The FDA has recently approved Crenessity (crinecerfont) for use alongside glucocorticoids in treating adults and children aged…
Read More
Medicare Proposal Expands Access to Care and Consumer Protections
CMS seeks to enhance Medicare Advantage and Part D programs, including coverage for anti-obesity medications. The Centers for Medicare and Medicaid Services (CMS) recently proposed updates to Medicare…
Read More